Boston Scientific Corp. (BSX)
44.64
-1.18
(-2.58%)
USD |
NYSE |
Nov 05, 16:00
44.12
-0.52
(-1.16%)
Pre-Market: 04:55
Boston Scientific SG&A Expense (TTM) : 7.101B for Sept. 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 7.101B |
| June 30, 2026 | 7.159B |
| March 31, 2026 | 7.072B |
| December 31, 2025 | 6.888B |
| September 30, 2025 | 6.666B |
| June 30, 2025 | 6.487B |
| March 31, 2025 | 6.217B |
| December 31, 2024 | 5.984B |
| September 30, 2024 | 5.751B |
| June 30, 2024 | 5.431B |
| March 31, 2024 | 5.339B |
| December 31, 2023 | 5.19B |
| September 30, 2023 | 4.974B |
| June 30, 2023 | 4.864B |
| March 31, 2023 | 4.675B |
| December 31, 2022 | 4.52B |
| September 30, 2022 | 4.51B |
| June 30, 2022 | 4.444B |
| March 31, 2022 | 4.40B |
| December 31, 2021 | 4.359B |
| September 30, 2021 | 4.233B |
| June 30, 2021 | 4.151B |
| March 31, 2021 | 3.828B |
| December 31, 2020 | 3.787B |
| September 30, 2020 | 3.852B |
| Date | Value |
|---|---|
| June 30, 2020 | 3.88B |
| March 31, 2020 | 4.05B |
| December 31, 2019 | 3.941B |
| September 30, 2019 | 3.802B |
| June 30, 2019 | 3.66B |
| March 31, 2019 | 3.578B |
| December 31, 2018 | 3.569B |
| September 30, 2018 | 3.502B |
| June 30, 2018 | 3.432B |
| March 31, 2018 | 3.361B |
| December 31, 2017 | 3.295B |
| September 30, 2017 | 3.24B |
| June 30, 2017 | 3.212B |
| March 31, 2017 | 3.176B |
| December 31, 2016 | 3.098B |
| September 30, 2016 | 3.044B |
| June 30, 2016 | 3.001B |
| March 31, 2016 | 2.922B |
| December 31, 2015 | 2.874B |
| September 30, 2015 | 2.849B |
| June 30, 2015 | 2.861B |
| March 31, 2015 | 2.904B |
| December 31, 2014 | 2.902B |
| September 30, 2014 | 2.874B |
| June 30, 2014 | 2.791B |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Abbott Laboratories | 15.16B |
| Becton, Dickinson & Co. | 3.867B |
| Stryker Corp. | 9.05B |
| Insulet Corp. | 993.40M |
| The Cooper Cos., Inc. | 1.887B |